OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Sodium glucose cotransporter 2 inhibitor suppresses renal injury in rats with renal congestion
Akari Endo, Takuo Hirose, Shigemitsu Sato, et al.
Hypertension Research (2023) Vol. 47, Iss. 1, pp. 33-45
Open Access | Times Cited: 7
Akari Endo, Takuo Hirose, Shigemitsu Sato, et al.
Hypertension Research (2023) Vol. 47, Iss. 1, pp. 33-45
Open Access | Times Cited: 7
Showing 7 citing articles:
The Renoprotective Mechanisms of Sodium-Glucose Cotransporter-2 Inhibitors (SGLT2i)—A Narrative Review
Liana Iordan, Laura Gaiţă, Romulus Timar, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 13, pp. 7057-7057
Open Access | Times Cited: 5
Liana Iordan, Laura Gaiţă, Romulus Timar, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 13, pp. 7057-7057
Open Access | Times Cited: 5
Sodium–Glucose Cotransporter 2 Inhibitor Combined with Conventional Diuretics Ameliorate Body Fluid Retention without Excessive Plasma Volume Reduction
Maki Asakura-Kinoshita, Takahiro Masuda, Kentaro Oka, et al.
Diagnostics (2024) Vol. 14, Iss. 11, pp. 1194-1194
Open Access | Times Cited: 4
Maki Asakura-Kinoshita, Takahiro Masuda, Kentaro Oka, et al.
Diagnostics (2024) Vol. 14, Iss. 11, pp. 1194-1194
Open Access | Times Cited: 4
Empagliflozin in nondiabetic individuals with calcium and uric acid kidney stones: a randomized phase 2 trial
Manuel Anderegg, Simeon Schietzel, Matteo Bargagli, et al.
Nature Medicine (2025)
Open Access
Manuel Anderegg, Simeon Schietzel, Matteo Bargagli, et al.
Nature Medicine (2025)
Open Access
The Impact of Sodium-Glucose Co-Transporter-2 Inhibition on Insulin Resistance and Inflammation in Patients with Type 2 Diabetes: A Retrospective Study
Liana Iordan, Sandra Lazăr, Romulus Timar, et al.
Medicina (2025) Vol. 61, Iss. 2, pp. 209-209
Open Access
Liana Iordan, Sandra Lazăr, Romulus Timar, et al.
Medicina (2025) Vol. 61, Iss. 2, pp. 209-209
Open Access
A case of acute appendicitis in a patient with minimal change disease
Fumiya Sato, S Nakayama, Takuo Hirose, et al.
CEN Case Reports (2025)
Closed Access
Fumiya Sato, S Nakayama, Takuo Hirose, et al.
CEN Case Reports (2025)
Closed Access
Tubular damage and SGLT2 expression in a patient with Beni-koji tablet-associated acute kidney injury and Fanconi syndrome
Ayaka Kamada, Takuo Hirose, H Hashimoto, et al.
CEN Case Reports (2025)
Closed Access
Ayaka Kamada, Takuo Hirose, H Hashimoto, et al.
CEN Case Reports (2025)
Closed Access
Sodium-glucose cotransporter 2 inhibitors: a novel approach to prevent the transition from acute kidney injury to chronic kidney disease
Miguel A. Martinez-Rojas, Norma A. Bobadilla
Current Opinion in Nephrology & Hypertension (2025)
Closed Access
Miguel A. Martinez-Rojas, Norma A. Bobadilla
Current Opinion in Nephrology & Hypertension (2025)
Closed Access
Interaction between SGLT2 and the sympathetic nervous system in normal and various cardiovascular metabolic disease states
Kenichi Katsurada
Hypertension Research (2025)
Closed Access
Kenichi Katsurada
Hypertension Research (2025)
Closed Access
Sodium glucose cotransporter 2 inhibitor as a promising therapy for congestive kidney injury
Kotaro Haruhara, Eisuke Kubo
Hypertension Research (2023) Vol. 47, Iss. 2, pp. 568-570
Open Access
Kotaro Haruhara, Eisuke Kubo
Hypertension Research (2023) Vol. 47, Iss. 2, pp. 568-570
Open Access
